We describe a case of systemic amyloidosis predominantly involving the liver. The patient presented with non-specific symptoms and deranged LFTs. Liver biopsy revealed characteristic findings of amyloidosis. The patient was treated with combination therapy and continues to have a good clinical response at four months’ follow-up. We briefly discuss the classification, presentation and management of amyloidosis.
Get full access to this article
View all access options for this article.
References
1.
McAdamKPWJ.Amyloidoses. In: McIntyre N, Benhamou JP, Bircher J, Rizzeto M, Rodes J (editors). Oxford Textbook of Clinical Hepatology. 1st ed. Oxford: Oxford Medical Publications; 1992; 779–87.
2.
KyleRAGertzMA.Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Haematol 1995; 32:45–59.
3.
WestermarkPMDBensonBuxbaumJN Amyloid fibril protein nomenclature – 2002. Amyloid 2002; 9(3):197–200.
4.
ThieleDLEigenbrodtEH.Hepatic manifestations of systemic disease. In: Feldman M, Scharschmidt BF, Sleisenger M (editors). Sleisenger and Fordtran, Gastrointestinal and Liver Disease. 6th ed. Philadelphia:WB Saunders; 1998; 1388–408.
5.
CohenASConorsLH.The pathogenesis and biochemistry of amyloidosis. J Pathol 1987; 151:1–5.
6.
Faa G,Van Eyken P, De Vos R Light chain deposition diseases of the liver associated with AL-type amyloidosis. J Hepatol 1991; 12:75–82.
7.
CohenASSkinerM. Amyloidosis of the liver. In: Schiff L, Schiff ER (editors). Diseases of the 6th edition. Philadelphia: JB Lippincott 1988; 1093–108.
8.
SherlockSh. Hepatic amyloidosis. In: Sherlock S Dooley J (editors). Diseases of the liver and biliary system. 10th ed. Oxford: Blackwell; 1997; 442–5.
9.
LovratLBMRPreseyMadhooS The liver in systemic amyloidosis. Gut 1988; 42:727–34.
10.
LociISumithanE. Morphological differences in the pattern of liver infiltration between AL and AA amyloidosis. Human Pathol 1988; 19:732–5.
11.
BuckFSJossMN.Hepatic amyloidosis: morphological differences between systemic AT and AA-types. Hum Pathol 1991; 22:904–7.
12.
IwataTZHoshiiKawanoH Hepatic amyloidosis in Japan: histological and morphologic analysis based on amyloid proteins. Hum Pathol 1995; 26:1148–53.
13.
GertyMAKyleRA.Hepatic amyloidosis: Clinical appraisal in 77 patients. Hepatology 1997; 25:118–21.
14.
BionERBrenardParienteEA.Sinusoidal portal hypertension in hepatic amyloidosis. Gut 1991; 32:227–30.
15.
PetersRAGKoukoulisGimsonA Primary amyloidosis and severe intrahepatic cholestatic jaundice. Gut 1994; 35:1322–25.
16.
Gertz MA,Kyle RA. Hepatic amyloidosis (AL):The natural history in 80 patients. Am J Med 1988; 95:73–80.
17.
GreggJATHerskovicBartholonceIG.Ascites in systemic amyloidosis. Arch Intern Med 1965; 116:605–10.
18.
ChopraSARubinowKoffRS Hepatic amyloidosis. A histological analysis of primary (AL) and secondary (AA) form. Am J Pathol 1984; 115:186–93.
19.
GrieppP.Amyloidosis (AL). An approach to early diagnosis. Arch Intern Med 1984; 144:2145–46.
20.
KyleRAPGrieppJPGartonGertzMA.Primary systemic amyloidosis. Comparison of melphalan/prednisone versus colchicine. Am J Med 1985; 79:708–16.
21.
KacemCKHelaliPuisieuxF. Recurrent spontaneous hepatic rupture in primary hepatic amyloidosis. Ann Intern Med 1998; 129:339.
